Microscopy

Life Science Microscopy Devices Market Report 2022: Featuring Danaher, Carl Zeiss, Thermo Fischer, Nikon, Bruker & Olympus and JEOL

Retrieved on: 
Saturday, January 28, 2023

The global life science microscopy devices market is expected to grow at a CAGR of 8.0% during the forecast period of 2022 to 2030.

Key Points: 
  • The global life science microscopy devices market is expected to grow at a CAGR of 8.0% during the forecast period of 2022 to 2030.
  • In the last two decades, tremendous technical revolution has taken place in the life science microscopy devices market.
  • Rising public health awareness resulting in early disease diagnosis and proactive role played by government, healthcare agencies to provide affordable healthcare to public drives the life science microscopy devices market growth.
  • However, concerns related to the high prices of advanced microscopes restrains the North America life science microscopy devices market.

Evvy Launches the First Vaginal Healthcare Platform to Combine Comprehensive Vaginal Microbiome Testing, Personalized Prescription Treatment, and 1-1 Health Coaching

Retrieved on: 
Wednesday, January 25, 2023

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- Vaginal discomfort is one of the leading reasons women seek healthcare advice, and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. Yet current standards for vaginal health testing and care don't take into account the entire vaginal microbiome. Instead, vaginal healthcare is underpinned by overly simplistic methods like microscopy and brute-force antibiotics.

Key Points: 
  • Yet current standards for vaginal health testing and care don't take into account the entire vaginal microbiome.
  • Instead, vaginal healthcare is underpinned by overly simplistic methods like microscopy and brute-force antibiotics.
  • Today, Evvy is announcing the expansion of its platform, which now offers end-to-end care, including physician-reviewed results and personalized prescription treatment programs, in addition to its groundbreaking Vaginal Health Test.
  • Users can access clinical care with Evvy after taking an Evvy Vaginal Health Test, depending on their results and health history.

IFF to Offer Two Newly Approved Animal Nutrition Solutions in Canada

Retrieved on: 
Monday, January 23, 2023

NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Danisco Animal Nutrition & Health, a business unit of IFF, today announced it has received approval from the Canadian Food Inspection Agency (CFIA) for Enviva® PRO and Syncra® SWI. The incorporation of the newly approved feed solutions in poultry and swine diets will allow producers in Canada to benefit from more consistent animal performance throughout the year. 

Key Points: 
  • The incorporation of the newly approved feed solutions in poultry and swine diets will allow producers in Canada to benefit from more consistent animal performance throughout the year.
  • It blends three Bacillus VMP strains which support the growth of beneficial bacteria and improve feed conversion ratios in broilers, layers, ducks and turkeys1.
  • "We are delighted to receive the formal recognition from the Canadian Food Inspection Agency (CFIA) that Enviva® PRO and Syncra® SWI are equally safe and effective for use in animals," said Regina Cortada, North America Animal Nutrition & Health leader, IFF.
  • By balancing nutrition, microbiome, and the gut and immune function, both solutions contribute to a favorable nutribiotic state, enabling animals to focus on growth.

Global Biophotonics Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts

Retrieved on: 
Tuesday, January 10, 2023

DUBLIN, Jan. 10, 2023 /PRNewswire/ -- The "Biophotonics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 10, 2023 /PRNewswire/ -- The "Biophotonics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global biophotonics market size reached US$ 44.8 Billion in 2021.
  • What has been the impact of COVID-19 on the global biophotonics market?
  • What is the structure of the global biophotonics market and who are the key players?

Insights on the Adaptive Optics Global Market to 2031 - Rising Prevalence of Retinal Degeneration Diseases Drives Growth

Retrieved on: 
Tuesday, January 10, 2023

The factors such as adoption in the field of astronomy, growing prevalence of retinal degeneration diseases, and rise in demand for high-resolution microscopy in various biomedical research operations supplement the growth of the adaptive optics market.

Key Points: 
  • The factors such as adoption in the field of astronomy, growing prevalence of retinal degeneration diseases, and rise in demand for high-resolution microscopy in various biomedical research operations supplement the growth of the adaptive optics market.
  • For the purpose of analysis, the global adaptive optics market is segmented on the basis of component, industry vertical, application, and region.
  • The report presents information related to the key drivers, restraints, and opportunities of the global adaptive optics market with a detailed impact analysis.
  • The current adaptive optics market is quantitatively analyzed from 2021 to 2031 to benchmark the financial competency.

$80.6 Billion Worldiwde Biophotonics Industry to 2027 - Featuring BD, Carl Zeiss, Lumenis and Thermo Fisher Scientific Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, January 6, 2023

Biophotonics refers to a multidisciplinary research field that uses light-based technologies to study life sciences and medicine.

Key Points: 
  • Biophotonics refers to a multidisciplinary research field that uses light-based technologies to study life sciences and medicine.
  • It involves the production and utilization of a light source to detect and manipulate biological materials.
  • As a result, biophotonics finds extensive applications in the fields of life sciences, agriculture, environmental science, dentistry and medicine.
  • Furthermore, the widespread adoption of biophotonics from the non-medical sector is creating a positive outlook for the market.

Uniformity Labs Ultra-Low Porosity UniFuse™ 316L 90um Stainless Steel Powder Delivers Improved Mechanical Properties at Much Higher Throughput for Laser Powder Bed Fusion

Retrieved on: 
Thursday, December 15, 2022

FREMONT, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Engineered materials company Uniformity Labs (Uniformity) announces the availability of its UniFuse™ 316L ultra-low porosity stainless steel powder.

Key Points: 
  • FREMONT, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Engineered materials company Uniformity Labs (Uniformity) announces the availability of its UniFuse™ 316L ultra-low porosity stainless steel powder.
  • Uniformity Labs UniFuse™ 316L ultra-low porosity powder and High-Performance Scanning (HPS) achieve an approximately 3X faster build time when compared to the competitor’s lower layer thickness scan strategies targeting best-in-class mechanical properties.
  • Compared to similar layer thickness builds, Uniformity Labs UniFuse™ 316L and HPS achieve far superior mechanical properties and build uniformity across the build platform with significantly increased throughput.
  • Higher bed and tap densities enable Uniformity powders to deliver improved mechanical properties and consistent performance across the build bed, even at high-speed build rates and thicker layer printing.

Biological Data Visualization Market Analysis Report 2022: A $1.3 Billion Market by 2030 - Focus on Microscopy, Sequencing, Systems, Biology - ResearchAndMarkets.com

Retrieved on: 
Friday, December 16, 2022

Rapid advancements in raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms.

Key Points: 
  • Rapid advancements in raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms.
  • By application, the genomic analysis segment is anticipated to have a significant share of the biological data visualization market in 2021.
  • By platform, Mac OS is anticipated to be the fastest-growing segment in the biological data visualization market.
  • Penetration & Growth Prospect Mapping for Application, 2021
    Biological Data Visualization Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological)

Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies

Retrieved on: 
Friday, December 16, 2022

RI

Key Points: 
  • RI
    Though still in the research phase, magnetic confinement fusion holds promise as a clean, abundant, sustainable, efficient and safe energy source.
  • Future fusion power plants could replace carbon dioxide-emitting fossil fuel plants, as well as nuclear fission reactors that generate long-lived radioactive waste.
  • BEST and RI have a long history of providing advanced technologies to tokamak and stellerator magnetic confinement fusion projects.
  • Many experts expect magnetic confinement fusion to lead to viable fusion power plants several decades before inertial confinement laser ignition may some day become useable for meaningful fusion power generation for the grid.

ZEISS Academy Africa inaugurated

Retrieved on: 
Friday, December 9, 2022

JOHANNESBURG, Dec. 9, 2022 /PRNewswire/ -- During his visit to Namibia and to South Africa this week, the German Federal Minister for Economic Affairs and Climate Action, Robert Habeck, joined the CFO of Carl Zeiss Meditec AG Justus Felix Wehmer and ZEISS South Africa head Seyfi Ceyhan for the inauguration of the ZEISS Academy Africa at the company's regional headquarters in Johannesburg.

Key Points: 
  • JOHANNESBURG, Dec. 9, 2022 /PRNewswire/ --During his visit to Namibia and to South Africa this week, the German Federal Minister for Economic Affairs and Climate Action, Robert Habeck, joined the CFO of Carl Zeiss Meditec AG Justus Felix Wehmer and ZEISS South Africa head Seyfi Ceyhan for the inauguration of the ZEISS Academy Africa at the company's regional headquarters in Johannesburg.
  • With a one million euro investment in equipment and facilities, the ZEISS Academy Africa is an important step to strengthen the presence of the company in South Africa and Sub-Saharan Africa.
  • Doctors and medical staff, engineers and researchers have access to hands-on training under near real-life conditions utilizing the most current ZEISS product portfolio.
  • The Academy Africa also supports children and youth, especially from underprivileged areas, giving them access to microscopy and encouraging them to get into STEM subjects.